Real work.
Real outcomes.
Research only matters if something happens because of it. Every case study here represents a decision that was made with more clarity , a market entered with confidence, a brand repositioned with evidence, a competitive move anticipated rather than reacted to.
Unlocking growth in targeted oncology therapy ,
4 markets to 6 in 8 weeks
An established pharma company had hit a growth ceiling at 6–7% YoY across 4 markets in its targeted oncology franchise. Cap7tara identified 3 expansion markets, designed differentiated patient access programs, and activated 50–100 oncologists per market , delivering +4pp prescription share gain in two months.
Read the Full Story →Unlocking growth in targeted oncology therapy , 4 markets to 6 in 8 weeks
An established pharma company had hit a growth ceiling at 6–7% YoY across 4 markets. Cap7tara identified 3 expansion markets, designed patient access programs, activated 50–100 oncologists, and delivered +4pp prescription share gain in two months.
Global laboratory chemical market: $2.1B opportunity mapped across 18 markets
A global life sciences leader was planning reactively in a market growing at 11.8% CAGR. 4,200+ primary interactions across 18 countries. Six priority categories. $2.1B in incremental opportunity identified. Execution began within 60 days of delivery.
Decoding the $20B AI Radiology market from intelligence to strategy
Seven strategic uncertainties resolved. Board-level investment case built. Entry wedge identified in emergency triage and oncology imaging , the two highest ROI-density segments in a rapidly consolidating market.